UC WAR. CALL 01/25 FRE/ DE000UG02F92 /
12/19/2024 1:40:04 PM | Chg.- | Bid2:07:37 PM | Ask12/19/2024 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
2.1400EUR | - | 2.1500 Bid Size: 20,000 |
- Ask Size: 15,000 |
FRESENIUS SE+CO.KGAA... | 32.00 - | 1/15/2025 | Call |
GlobeNewswire
4/24/2024
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
4/23/2024
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
2/23/2024
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
9/4/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
8/31/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil